At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 56 enrolled
Drug / intervention
0.25% Bupivacaine + Clonidinedrug
Likely dose
0.25% Bupivacaine + Clonidine 2mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery: Does the Addition of Clonidine Increase the Duration of Postoperative Analgesia?
Ann & Robert H Lurie Children's Hospital of Chicago·interventional·Posted Jul 11, 2012·Updated Aug 4, 2021
In Brief
A Phase 2 clinical trial evaluating 0.25% Bupivacaine + Clonidine for Tympanomastoid Surgery and 3 related conditions. Completed, enrolled 56 participants across 1 site.
Detailed Summary
The investigators goal is to determine the efficacy and duration of analgesia with the addition of Clonidine, an alpha-2 agonist, to local anesthetic blockade using bupivacaine, of the great auricular nerve in children undergoing tympanomastoid surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTympanomastoid Surgery, Cochlear Implant, Mastoidectomy, Cholesteatoma
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2006
Primary CompletionMar 2008
Study CompletionApr 2008
First PostedJul 2012
TodayJul 2026
First PostedJul 11, 2012
Enrollment StartFeb 1, 2006
Primary CompletionMar 1, 2008
Study CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.0 years ago
Interventions
0.25% Bupivacaine + Clonidinedrug
Patients will receive 2mL of 0.25% bupivacaine with 2mcg/ml of clonidine